Sammanfattning
Mean S-TK1 activities were 1.11 +/- 0.46 pmol/min/mL in healthy dogs and 1.15 +/- 0.32 pmol/min/mL in healthy humans. S-TK1 activities in dogs with hematological malignancies were 24.2 +/- 47.9 pmol/min/mL, and the receiver operating characteristic curve showed an area under the curve of 0.88. With a cut-off value of 1.9 pmol/min/mL (mean value +/- 2 SD), the sensitivity was 0.94 and the specificity was 0.68. Very similar results were obtained with human samples (healthy and lymphoma cases). S-TK1 activities measured during chemotherapy of six dogs with lymphoma were drastically reduced. In one case, S-TK1 activity increased prior to relapse. S-TK1 levels in dogs with solid tumors did not differ from the healthy group. S-TK1 activities correlated with those determined with the TK-REA and TK-Liaison assays (r = 0.92 and r = 0.96, respectively). In conclusion, this optimized [H-3]-dThd assay is fast, sensitive and economical for measuring S-TK1 activity and should increase its clinical use as biomarker. (C) 2012 Elsevier Ltd. All rights reserved.
| Originalspråk | Engelska |
|---|---|
| Sidor (från-till) | 40-47 |
| Antal sidor | 8 |
| Tidskrift | Veterinary Journal |
| Volym | 194 |
| Nummer | 1 |
| DOI | |
| Status | Publicerad - 2012 |
Nyckelord
- Thymidine kinase 1
- Canine
- Lymphoma
- Radioenzymatic method
- Biomarker
- Prognosis
Citera det här
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver